Triple

T22690288
Position Surface form Disambiguated ID Type / Status
Subject CDK4 E561032 entity
Predicate formsComplexWith P6653 FINISHED
Object cyclin D2
Cyclin D2 is a regulatory protein that controls progression through the G1 phase of the cell cycle by activating cyclin-dependent kinases involved in cell proliferation.
 E1549317 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: cyclin D2 | Statement: [CDK4, formsComplexWith, cyclin D2]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: cyclin D2
Context triple: [CDK4, formsComplexWith, cyclin D2]
  • A. CDK4
    CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
  • B. CDK6
    CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
  • C. B-type cyclins
    B-type cyclins are regulatory proteins that control progression through mitosis in eukaryotic cells by activating cyclin-dependent kinases.
  • D. Cdh1
    Cdh1 is a regulatory protein that activates the anaphase-promoting complex/cyclosome (APC/C) to control mitotic exit and G1 phase progression in the cell cycle.
  • E. Cdc28
    Cdc28 is the major cyclin-dependent kinase in budding yeast that drives progression through the cell cycle by phosphorylating key regulatory proteins.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: cyclin D2
Triple: [CDK4, formsComplexWith, cyclin D2]
Generated description
Cyclin D2 is a regulatory protein that controls progression through the G1 phase of the cell cycle by activating cyclin-dependent kinases involved in cell proliferation.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: cyclin D2
Target entity description: Cyclin D2 is a regulatory protein that controls progression through the G1 phase of the cell cycle by activating cyclin-dependent kinases involved in cell proliferation.
  • A. CDK4
    CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
  • B. CDK6
    CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
  • C. B-type cyclins
    B-type cyclins are regulatory proteins that control progression through mitosis in eukaryotic cells by activating cyclin-dependent kinases.
  • D. Cdh1
    Cdh1 is a regulatory protein that activates the anaphase-promoting complex/cyclosome (APC/C) to control mitotic exit and G1 phase progression in the cell cycle.
  • E. Cdc28
    Cdc28 is the major cyclin-dependent kinase in budding yeast that drives progression through the cell cycle by phosphorylating key regulatory proteins.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454d71b48190a1f80af9f82b6fcf completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1789a1fd08190bce5fa0babe695d3 completed April 29, 2026, 3:18 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0b73fa5a648190b90ba303d1fe2397 completed May 18, 2026, 8:18 p.m.
NEDg Description generation batch_6a0b7755eb048190ba1657a9a09bc24b completed May 18, 2026, 8:32 p.m.
NED2 Entity disambiguation (via description) batch_6a0b780c0a4c8190b51b50c1e0e1a114 completed May 18, 2026, 8:35 p.m.
Created at: April 17, 2026, 3:13 p.m.